Quark's siRNA again fails to charm public market: withdraws IPO offer
29 September 2011
Nancy Faigen
Please Login to read the full article.
29 September 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Cancer developer Merrimack dives into a tough IPO pool with a $172M filing
- TVAX Biomedical plans killer $40M IPO to fund PhIII vaccine for naive astrocytoma
- US Capitol Capsule: Group proposes efforts to ensure US innovation competitiveness
- Broad swathe of measures to support UK life sciences draws widespread applause
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
